BackFive Prime Therapeutics Overview

Five Prime Therapeutics Goodwill

Track Five Prime Therapeutics's goodwill ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer average / median

Loading

Five Prime Therapeutics Goodwill History

Loading

Five Prime Therapeutics vs. peers: Goodwill Comparison

Loading

Five Prime Therapeutics Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Five Prime Therapeutics (FPRX) FAQ

Five Prime Therapeutics's goodwill stands at $0 as of December 2020. In the prior-year period, the figure was $0. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Five Prime Therapeutics reported $0 in goodwill versus $0 a year earlier. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

In the prior-year period, the figure was $0. Sustained growth in goodwill can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Five Prime Therapeutics's goodwill evolved across reporting periods, while the comparison chart places FPRX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, goodwill is commonly used to spot outliers. Five Prime Therapeutics's reading of $0 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.